Perth Biodesign's EarFlo Device Approved in US
Perth-based Perth Biodesign has received FDA approval for its EarFlo device, treating childhood ear infections non-invasively via a sippy cup. The device aims for Australian market by mid-2027.
Category : Biotechnology
WA Biotech Targets Insulin Resistance with RNA Therapy
A Western Australian biotech collaboration is developing RNA-based therapies to target insulin resistance, complementing GLP-1 drugs like Ozempic and aiming to address underlying diabetes causes.
St George Mining's Brazil Project Hits Rare Earths and Niobium
St George Mining's Araxá project in Brazil delivers thick rare earths and niobium intercepts from surface, expanding the mineralised footprint beyond the current resource estimate.
Australian Brain Injury Breakthrough Nears Clinical Trials
Australian researchers are close to a breakthrough treatment for traumatic brain injury, using nasal cells to repair damaged brain tissue and restore lost functions.
This Free Telegram App Replaces Your Messy Shopping Notes
Shared lists with real-time sync. No signup needed — just open and shop together.
Recommended
WA Scientists to Test Zero-Gravity Tech for Mars Missions
University of Western Australia researchers will become the first all-Australian scientific crew to experience zero gravity on a parabolic flight, testing chemical catalysis for producing fuel on Mars.
30-Year Stroke Drug Research Finds Home in Hunter
Professor Shaun Jackson's 30-year stroke drug research relocates to the Hunter region, promising new treatments and local economic benefits.
Mount Ridley hires Chris Larder as technical advisor
Mount Ridley Mines has appointed Chris Larder, a process engineer with over 30 years of experience, as technical advisor for metallurgy and processing to fast-track downstream processing at its Mount Ridley project in WA.
Stroke Drug TBO-309 Shows Promise in Newcastle Trials
A novel anti-clotting drug developed in Newcastle, TBO-309, has shown remarkable results in early trials, offering hope for stroke patients with fewer bleeding risks.
Lindian Secures Sulphuric Acid Supply for Kazakhstan Plant
Lindian Resources has locked in a long-term, low-cost sulphuric acid supply deal with a state-backed Kazakh producer, just before China's expected export ban, bolstering its rare earths downstream strategy.
This Free Telegram App Replaces Your Messy Shopping Notes
Shared lists with real-time sync. No signup needed — just open and shop together.
Recommended
New Townsville Graphite Plant to Break China's Battery Grip
A new graphite processing plant in Townsville aims to reduce Australia's reliance on China for battery materials, boosting local supply chains and the economy.
Butterfly boy walks after gene therapy gel
Jacob Burmeister, a four-year-old with Epidermolysis Bullosa, can walk again after a groundbreaking gel restored his ability to move. The treatment delivers a missing gene copy.
One-off treatment for rare blood cancers in WA trial
A groundbreaking trial at Fiona Stanley Hospital offers a one-off treatment for rare blood cancers, potentially revolutionising care for patients with limited options.
PhD Honours Mother's Cancer Journey: Giverny Witheridge
Giverny Witheridge's PhD research on cancer treatment is deeply personal, inspired by her mother's battle with the disease. Her work aims to improve therapies.
Perth Lab Pioneers Human-Grade DNA and RNA Manufacturing
Syngenis Laboratories in Perth is building Australia's only commercial GMP facility for synthetic oligonucleotides, aiming to capture $160 million in offshore work and boost local biotech innovation.
This Free Telegram App Replaces Your Messy Shopping Notes
Shared lists with real-time sync. No signup needed — just open and shop together.
Recommended
$3M Grant for Bee 'Glue' Health Research in Bibra Lake
Red Earth Pollen receives $3 million to develop propolis into bioactive ingredients for pharmaceutical and therapeutic applications, creating Australia's first comprehensive extraction ecosystem.
NeuroScientific Boosts Stem Cell Production for Crohn's Trials
NeuroScientific Biopharmaceuticals has initiated a technology transfer to Q-Gen in Brisbane, scaling up StemSmart stem cell manufacturing for upcoming Crohn's disease clinical trials.
Oncores Secures $30M for Breast Cancer Detection Probe
Australian biotech firm Oncores has raised nearly $30 million in funding to advance its innovative breast cancer detection probe, aiming to improve early diagnosis and patient outcomes through cutting-edge technology.
SA Health Tech Lands Record Early Funding
A South Australian health technology company has achieved the largest early-stage funding raise in the state's history, marking a significant milestone for the local tech sector.
Graham Melrose: Chemist Innovator in Home and Hospital
Graham Melrose, a chemist known for his innovative work in both home and hospital settings, has passed away. His contributions advanced healthcare and consumer products.
This Free Telegram App Replaces Your Messy Shopping Notes
Shared lists with real-time sync. No signup needed — just open and shop together.
Recommended
PYC Therapeutics $653M Equity Raising for Drugs
Perth-based biotech firm PYC Therapeutics announces a $653 million equity raising to fund the advancement of its innovative drug portfolio, targeting key therapeutic areas.
FDA fast-tracks Singular Health medical imaging software
Perth's Singular Health secures accelerated FDA clearance for its cloud-based 3DICOM MD Cloud, targeting US$16.5bn in healthcare inefficiencies. Read how this Australian innovation transforms medical imaging.
Biotech Soars on Real-World Stem Cell Therapy Results
NeuroScientific Biopharmaceuticals shares surge after its StemSmart stem cell therapy shows significant clinical response in patients with fistulising Crohn's disease, validating its $5.1m acquisition.
Funnel Web Spider Venom Drug Enters Human Trials
Queensland researchers begin human trials for IB409, a revolutionary drug derived from funnel web spider venom that could prevent cell death during heart attacks and strokes.
Singular Health files FDA application for 3DICOM Cloud
Perth-based Singular Health Group submits 510(k) to US FDA for its cloud-based 3D medical imaging platform. Approval could transform global healthcare access and slash duplicate scan costs.
This Free Telegram App Replaces Your Messy Shopping Notes
Shared lists with real-time sync. No signup needed — just open and shop together.
Recommended
Ex-Woodside CEO Peter Coleman leads PYC Therapeutics
Former Woodside Energy boss Peter Coleman takes helm at PYC Therapeutics following board crisis and managing director's brief resignation. Key leadership change aims to restore investor confidence.
Fourth Crohn's Patient Treated with Stem Cell Therapy
NeuroScientific Biopharmaceuticals has dosed a fourth patient with its StemSmart stem-cell therapy for fistulising Crohn's disease, marking a key step for the Australian biotech. Discover the potential of this game-changing treatment.
WA innovators score PM's top science honour for medical breakthrough
Two Western Australian researchers have claimed Australia's most prestigious science awards for developing revolutionary technology that could transform emergency medicine worldwide.
UOW's revolutionary device targets pancreatic cancer
University of Wollongong researchers develop groundbreaking implant technology that could transform pancreatic cancer treatment in Australian healthcare.
Page 1 of 1
